HS
GBIO

HighVista Strategies’s Generation Bio GBIO Stock Holding History

HighVista Strategies’s Portfolio GBIO Stock Details GBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-13,888
Closed -$546K – 118
2022
Q4 		$546K Sell
13,888
-11,011
-44% -$578K 0.32% 72
2022
Q3 		$1.32M Hold
24,899
– – 0.76% 36
2022
Q2 		$1.63M Buy
24,899
+11,769
+90% +$769K 0.99% 33
2022
Q1 		$964K Buy
+13,130
New +$761K 0.61% 39

Other funds holding GBIO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

HighVista Strategies's GBIO Position: Q1 2023 in Review

HighVista Strategies sold out of Generation Bio (GBIO) in Q1 2023, closing a stake of 13,888 shares — an estimated $546K sold.

HighVista Strategies first reported a position in GBIO in Q1 2022 and held it in 4 quarters. The position peaked at $1.63M in Q2 2022. 83 funds tracked by Wall St. Rank hold GBIO as of Q1 2023.

  • HighVista Strategies reported no remaining Generation Bio position as of Q1 2023 after selling out during the quarter.
  • HighVista Strategies sold 13,888 Generation Bio shares in Q1 2023, an estimated $546K.
  • HighVista Strategies first reported a position in Generation Bio in Q1 2022 and held it in 4 quarters.
  • HighVista Strategies's Generation Bio position peaked at $1.63M in Q2 2022.
  • 83 funds tracked by Wall St. Rank held Generation Bio as of Q1 2023.

Based on HighVista Strategies's 13F filing for Q1 2023, filed 15 May 2023.